
Ticasave Plus Tablet
Marketer
Eris Lifesciences Ltd
Salt Composition
Ticagrelor (90mg)
Overview Ticasave Plus Tablet
CardioGuard Plus tablets are antiplatelet agents, also known as blood thinners. They inhibit the formation of dangerous blood clots within blood vessels, thereby lowering the risk of stroke or heart attack in individuals with cardiovascular conditions. CardioGuard Plus is also indicated for patients recovering from a heart attack, experiencing severe angina (chest pain), or who have recently undergone coronary stenting. Its use helps prevent future cardiac events, including repeat heart attacks, stroke, or clot formation within stents. Concomitant use with aspirin, another antiplatelet medication, is typical. CardioGuard Plus can be taken with or without food, but consistent daily dosing is crucial for efficacy. Discontinuing treatment significantly increases the risk of recurrent cardiac events. The most prevalent side effect is increased bleeding tendency; injuries may bleed more profusely and for longer periods. While usually mild and self-limiting, prolonged or excessive bleeding requires medical attention. Some patients may experience mild shortness of breath, which generally subsides with continued therapy; however, persistent or worsening breathlessness should be reported. CardioGuard Plus is contraindicated in patients with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Always disclose relevant medical history to your physician before commencing treatment.
Uses of Ticasave Plus Tablet
Avoiding heart attacks and strokes
Major Benefits of Ticasave Plus Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Ticasave Plus Tablets can be administered with or without food, but consistent timing is recommended.
Common Side effects of Ticasave Plus Tablet:
- Bleeding
- Breathlessness
How to use Ticasave Plus Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Ticasave Plus Tablets can be taken with or without food, but consistent timing is recommended.
How Ticasave Plus Tablet works:
Ticasave Plus Tablets are antiplatelet agents that inhibit platelet aggregation, thus reducing the risk of dangerous blood clot development and consequently lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ticasave Plus Tablet with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Ticasave Plus Tablet during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Ticasave Plus Tablet with breastfeeding is absent. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticasave Plus Tablet.
KidneySAFE IF PRESCRIBED
Ticasave Plus Tablets are considered safe for patients with kidney impairment; no dosage modification is advised. Data regarding Ticasave Plus Tablet use in individuals undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should exercise caution when using Ticasave Plus Tablets; dosage modification may be necessary. Consult a physician before use. Ticasave Plus Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Ticasave Plus Tablet :
Should you forget a Ticasave Plus Tablet dose, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticasave Plus Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
